{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:37:58Z","timestamp":1786117078258,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["899708"],"award-info":[{"award-number":["899708"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science Innovation and Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006301","name":"Center for International Business Education and Research, University of Illinois at Urbana-Champaign","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"&apos;la Caixa&apos; Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.biopha.2025.118919","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:34:21Z","timestamp":1767681261000},"page":"118919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Folate- and aCD47-functionalized lipid nanoparticles efficiently deliver mRNA and remodel pancreatic tumor microenvironment"],"prefix":"10.1016","volume":"194","author":[{"given":"Marta","family":"Par\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5421-5371","authenticated-orcid":false,"given":"Javier","family":"Mart\u00ednez-Latorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Candela-Noguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula M.","family":"Soriano-Teruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Garc\u00eda-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Pallaruelo-Santamar\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Aznar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Mart\u00ednez-M\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0801-3338","authenticated-orcid":false,"given":"Cristina","family":"Fillat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118919_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated projection of US cancer incidence and death to 2040","volume":"4","author":"Rahib","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.biopha.2025.118919_bib2","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2025.118919_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.688377","article-title":"The current treatment paradigm for pancreatic ductal adenocarcinoma and barriers to therapeutic efficacy","volume":"11","author":"Principe","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2025.118919_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/medicina54030048","article-title":"Chemotherapy in pancreatic cancer: a systematic review","volume":"54","author":"Hajatdoost","year":"2018","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.biopha.2025.118919_bib5","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.gastro.2020.10.007","article-title":"Worldwide burden of, risk factors for, and trends in pancreatic cancer","volume":"160","author":"Huang","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2025.118919_bib6","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3390\/jcm14041129","article-title":"Current and emerging treatment options for pancreatic cancer: a comprehensive review","volume":"14","author":"Hayat","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2025.118919_bib7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13046-022-02273-w","article-title":"Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy","volume":"41","author":"Liu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118919_bib8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13045-019-0822-6","article-title":"Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer","volume":"12","author":"Pan","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2025.118919_bib9","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1158\/1078-0432.CCR-17-2283","article-title":"CD47 blockade as an adjuvant immunotherapy for resectable pancreatic cancer","volume":"24","author":"Michaels","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118919_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118919_bib11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S1470-2045(24)00079-2","article-title":"LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1\/2 study","volume":"25","author":"Musher","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2025.118919_bib12","article-title":"KPC pancreatic cancer cells are a novel immunocompetent murine model supporting human adenovirus replication and tumor oncolysis","volume":"33","author":"Otero-Mateo","year":"2024","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.biopha.2025.118919_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102016","article-title":"Immunotherapy for pancreatic cancer: a 2020 update","volume":"86","author":"Schizas","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.biopha.2025.118919_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103434","article-title":"Engineered nanomedicines to overcome resistance of pancreatic cancer to immunotherapy","volume":"28","author":"Elzoghby","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2025.118919_bib15","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.2147\/IJN.S466459","article-title":"Emerging nanotechnology in preclinical pancreatic cancer immunotherapy: driving towards clinical applications","volume":"19","author":"Pan","year":"2024","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.biopha.2025.118919_bib16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2025.118919_bib17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41568-019-0186-9","article-title":"Improving cancer immunotherapy through nanotechnology","volume":"19","author":"Goldberg","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2025.118919_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202203033","article-title":"High-precision synthesis of RNA-loaded lipid nanoparticles for biomedical applications","volume":"12","author":"Seo","year":"2023","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.biopha.2025.118919_bib19","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.biopha.2025.118919_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.52601\/bpr.2023.230022","article-title":"Surface engineering of lipid nanoparticles: targeted nucleic acid delivery and beyond","volume":"9","author":"Lin","year":"2023","journal-title":"Biophys. Rep."},{"key":"10.1016\/j.biopha.2025.118919_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113588","article-title":"Pancreas-targeted lipid nanoparticles for relatively non-invasive interleukin-12 mRNA therapy in orthotopic pancreatic ductal adenocarcinoma","volume":"381","author":"Shen","year":"2025","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2025.118919_bib22","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.2147\/IJN.S462213","article-title":"Delivery of a STING agonist using lipid nanoparticles inhibits pancreatic cancer growth","volume":"19","author":"Shaji","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2025.118919_bib23","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1021\/acsnano.4c14102","article-title":"Reprogramming the tolerogenic immune response against pancreatic cancer metastases by lipid nanoparticles delivering a STING agonist plus mutant KRAS mRNA","volume":"19","author":"Xu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.118919_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2023.03.016","article-title":"Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors","volume":"357","author":"Anthiya","year":"2023","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2025.118919_bib25","doi-asserted-by":"crossref","first-page":"22700","DOI":"10.18632\/oncotarget.15169","article-title":"A NOTCH-sensitive uPAR-regulated oncolytic adenovirus effectively suppresses pancreatic tumor growth and triggers synergistic anticancer effects with gemcitabine and nab-paclitaxel","volume":"8","author":"Mato-Berciano","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118919_bib26","doi-asserted-by":"crossref","first-page":"22700","DOI":"10.1016\/j.currproblcancer.2022.100917","article-title":"Folate Receptor as a biomarker and therapeutic target in solid tumors","volume":"47","author":"Young","year":"2023","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.biopha.2025.118919_bib27","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/S0006-3495(01)76202-9","article-title":"Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes","volume":"80","author":"Maurer","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.biopha.2025.118919_bib28","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.nano.2016.12.014","article-title":"Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA","volume":"13","author":"Kulkarni","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2025.118919_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-62703-550-7_11","article-title":"Tips for the functionalization of nanoparticles with antibodies","volume":"1051","author":"Polo","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2025.118919_bib30","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1039\/D2BM00168C","article-title":"In vivo delivery of plasmid DNA by lipid nanoparticles: the influence of ionizable cationic lipids on organ-selective gene expression","volume":"10","author":"Algarni","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biopha.2025.118919_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0002-9440(10)65567-8","article-title":"Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma","volume":"153","author":"Liu","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2025.118919_bib32","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.2147\/IJN.S363990","article-title":"Optimization of lipid nanoformulations for effective mRNA delivery","volume":"17","author":"Chen","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2025.118919_bib33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1208\/s12249-022-02294-w","article-title":"Optimization of DOTAP\/chol cationic lipid nanoparticles for mRNA, pDNA, and oligonucleotide delivery","volume":"23","author":"Sun","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biopha.2025.118919_bib34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s42003-022-03021-8","article-title":"Transfected plasmid DNA is incorporated into the nucleus via nuclear envelope reformation at telophase","volume":"5","author":"Haraguchi","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.biopha.2025.118919_bib35","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3390\/pharmaceutics14122682","article-title":"Recent advances in lipid nanoparticles for delivery of mRNA","volume":"14","author":"Yang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2025.118919_bib36","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1038\/s41467-020-19486-2","article-title":"In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo","volume":"11","author":"Parayath","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118919_bib37","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1593\/neo.81674","article-title":"Urokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse models","volume":"11","author":"Huch","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.biopha.2025.118919_bib38","article-title":"Anti-CD47 treatment stimulates phagocytosis of glioblastoma by M1 and M2 polarized macrophages and promotes M1 polarized macrophages in vivo","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118919_bib39","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.2147\/IJN.S36111","article-title":"The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles","author":"Fr\u00f6hlich","year":"2012","journal-title":"Int. J. Nanomed. 7"},{"key":"10.1016\/j.biopha.2025.118919_bib40","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2025.118919_bib41","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1242\/jcs.066399","article-title":"Breaking down the barriers: siRNA delivery and endosome escape","volume":"123","author":"Dominska","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.biopha.2025.118919_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat9143","article-title":"Durable anticancer immunity from intratumoral administration of IL-23, IL-36\u03b3, and OX40L mRNAs","volume":"11","author":"Hewitt","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2025.118919_bib43","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.3390\/nano13152225","article-title":"Recent studies and progress in the intratumoral administration of nano-sized drug delivery systems","volume":"13","author":"Yun","year":"2023","journal-title":"Nanomater. (Basel)"},{"key":"10.1016\/j.biopha.2025.118919_bib44","doi-asserted-by":"crossref","first-page":"10635","DOI":"10.1038\/s41467-024-54877-9","article-title":"Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunity","volume":"15","author":"Hamouda","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118919_bib45","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4049\/jimmunol.2100352","article-title":"CD47 blockade leads to chemokine-dependent monocyte infiltration and loss of B cells from the splenic marginal zone","volume":"208","author":"Yiu","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2025.118919_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.607209","article-title":"Tumor-associated macrophages in pancreatic ductal adenocarcinoma: origin, polarization, function, and reprogramming","volume":"8","author":"Yang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2025.118919_bib47","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/s41467-024-55424-2","article-title":"Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms","volume":"16","author":"Sivakumar","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118919_bib48","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200839","article-title":"The SIRP\u03b1-CD47 immune checkpoint in NK cells","volume":"218","author":"Deuse","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2025.118919_bib49","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00262-025-04032-0","article-title":"Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapy","volume":"74","author":"Reischer","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.biopha.2025.118919_bib50","doi-asserted-by":"crossref","first-page":"11103","DOI":"10.1073\/pnas.1305569110","article-title":"Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response","volume":"110","author":"Tseng","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.118919_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217934","article-title":"A novel oncolytic poxvirus carrying CD47 nanomabs in the treatment of pancreatic cancer by reshaping the immune microenvironment","volume":"632","author":"Chen","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2025.118919_bib52","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2022.03.021","article-title":"Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy","volume":"345","author":"Liu","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2025.118919_bib53","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1038\/s41467-025-58548-1","article-title":"Nanoparticle delivery of a prodrug-activating bacterial enzyme leads to anti-tumor responses","volume":"16","author":"Huayamares","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118919_bib54","doi-asserted-by":"crossref","first-page":"24560","DOI":"10.18632\/oncotarget.4183","article-title":"RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients","volume":"6","author":"Golan","year":"2015","journal-title":"Oncotarget"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:11:30Z","timestamp":1786021890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225011138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":54,"alternative-id":["S0753332225011138"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118919","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Folate- and aCD47-functionalized lipid nanoparticles efficiently deliver mRNA and remodel pancreatic tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118919"}}